Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 21, 2023

SELL
$27.49 - $46.9 $42,004 - $71,663
-1,528 Reduced 7.65%
18,443 $583,000
Q4 2022

Feb 22, 2023

BUY
$17.18 - $33.0 $343,101 - $659,043
19,971 New
19,971 $619,000

Others Institutions Holding ACLX

About Arcellx, Inc.


  • Ticker ACLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,819,200
  • Market Cap $3.31B
  • Description
  • Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...
More about ACLX
Track This Portfolio

Track Teachers Retirement System Of The State Of Kentucky Portfolio

Follow Teachers Retirement System Of The State Of Kentucky and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teachers Retirement System Of The State Of Kentucky, based on Form 13F filings with the SEC.

News

Stay updated on Teachers Retirement System Of The State Of Kentucky with notifications on news.